Dave S.�B. Hoon

72.9k citations

407 papers · 21.8k indexed · 2 hit papers · h-index 79

Impact in

Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Oncology top 0.1%
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 140
- Cancer Genomics and Diagnostics 90
Immunology 160
- Immunotherapy and Immune Responses 124

Co-authors: Klaus Pantel Heidi Schwarzenbach Donald L. Morton Christine Kuo Roderick R. Turner Armando E. Giuliano Bret Taback Hiroya Takeuchi
Journals: Journal of Clinical Oncology (40 papers)Clinical Cancer Research (23 papers)Cancer Research (19 papers)International Journal of Cancer (16 papers)Cancers (12 papers)
Partner nations: United States Japan Israel

In The Last Decade

Dave S.�B. Hoon

393 papers receiving 21.4k citations

Hit Papers

align trajectories log scale

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA 2015 · 470 citations

Peers

Countries citing papers authored by Dave S.�B. Hoon

Since Specialization

Citations

This map shows the geographic impact of Dave S.�B. Hoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave S.�B. Hoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave S.�B. Hoon more than expected).

Fields of papers citing papers by Dave S.�B. Hoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave S.�B. Hoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave S.�B. Hoon. The network helps show where Dave S.�B. Hoon may publish in the future.

Co-authors

The 25 scholars most cited alongside Dave S.�B. Hoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dave S.�B. Hoon Line = papers co-authored together Dave S.�B. Hoon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers Nature Cancer ·Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S. El‐Deiry, Emmanuel S. Antonarakis, Stephanie L. Graff, Michael J. Hall, Hossein Borghaei, Dave S.�B. Hoon, Stephen V. Liu, C. Patrick, Rana R. McKay, Trisha M. Wise‐Draper, John L. Marshall, George W. Sledge, David Spetzler, Hao Zhu, David Hsiehchen	2024	11
2	Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells JCI Insight ·Hunter D. Reavis, Stefan Gysler, Grace B. McKenney, Matthew Knarr, Hannah J. Lusk, Priyanka Rawat, Hannah S. Rendulich, Marilyn A. Mitchell, Dara S. Berger, Jamie S. Moon, Suyeon Ryu, Monica Mainigi, Marcin Iwanicki, Dave S.�B. Hoon, Laura M. Sanchez, Ronny Drapkin	2024	11
3	Characterization of FOLH1 Expression in Renal Cell Carcinoma Cancers ·Eric Royz, Elizabeth Pan, Melis Güer, Andrew Elliott, Shankar Siva, Praful Ravi, Bradley A. McGregor, Aditya Bagrodia, Ithaar Derweesh, Pedro C. Barata, Elisabeth I. Heath, Emmanuel S. Antonarakis, Sourat Darabi, Dave S.�B. Hoon, Amir Mortazavi, Toni Choueiri, Chadi Nabhan, Shuanzeng Wei, Rana R. McKay	2024	1
4	Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma Clinical Cancer Research ·Santosh Kesari, Naveed Wagle, Jose Carrillo, Akanksha Sharma, Minhdan Nguyen, Judy Truong, Jaya M. Gill, Raffi Nersesian, Natsuko Nomura, Elnaz Rahbarlayegh, Garni Barkhoudarian, Walavan Sivakumar, Daniel F. Kelly, Howard Krauss, Matías A. Bustos, Dave S.�B. Hoon, Lars Anker, Arun S. Singh, Kamalesh K. Sankhala, Tiffany Juarez	2023	3
5	Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood Cancers ·Paul Geus, Felix Hehnen, Sophia Krakowski, Klaus Lücke, Dave S.�B. Hoon, Nikolaj Frost, Ulrich Kertzscher, Gabi Wendt	2022	1
6	The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes Clinical Cancer Research ·Matthew P. Salomon, Xiaowen Wang, Diego M. Marzese, Sandy Hsu, Nellie Nelson, Xin Zhang, Chikako Matsuba, Yuki Takasumi, Carmen Ballesteros‐Merino, Bernard A. Fox, Garni Barkhoudarian, Daniel F. Kelly, Dave S.�B. Hoon	2018	90
7	KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer Molecular Cancer Therapeutics ·Wenyu Wang, Keng Gat Lim, Min Feng, Bao Yi, Puay Leng Lee, Yu Cai, Yufeng Chen, Hao Zhang, Diego M. Marzese, Dave S.�B. Hoon, Qiang Yu	2018	39
8	Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer Cancer Research ·Jagmohan Hooda, Marián Novak, Matthew P. Salomon, Chikako Matsuba, Romela Irene Ramos, Emily MacDuffie, Melissa Song, Michelle S. Hirsch, Jenny Lester, Vinita Parkash, Beth Y. Karlan, Moshe Oren, Dave S.�B. Hoon, Ronny Drapkin	2018	40
9	Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma Clinical Cancer Research ·Yuuki Iida, Aaron Ciechanover, Diego M. Marzese, Keisuke Hata, Matías A. Bustos, Shigeshi Ono, Jinhua Wang, Matthew P. Salomon, Kevin Tran, Stella Lam, Sandy Hsu, Nellie Nelson, Yelena Kravtsova‐Ivantsiv, Gordon B. Mills, Michael A. Davies, Dave S.�B. Hoon	2017	29
10	B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients Clinical Cancer Research ·Yu Yao, Hongxing Ye, Zengxin Qi, Lianjie Mo, Yue Qi, Aparajita Baral, Dave S.�B. Hoon, Juan Carlos Vera, John D. Heiss, Clark C. Chen, Wei Hua, Jianmin Zhang, Kunlin Jin, Yin Wang, Xingxing Zang, Ying Mao, Liangfu Zhou	2016	148
11	Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis Proceedings of the National Academy of Sciences ·Shuet Theng Lee, Min Feng, Yong Wei, Zhimei Li, Yuanyuan Qiao, Peiyong Guan, Xia Jiang, Chew Hooi Wong, Kelly Huynh, Jinhua Wang, Juntao Li, Krishina M. Karuturi, Ern Yu Tan, Dave S.�B. Hoon, Yibin Kang, Qiang Yu	2013	55
12	FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer Cancer Research ·Partha Ray, Jinhua Wang, Ying Qu, Myung‐Shin Sim, Jaime Shamonki, Sanjay P. Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S.�B. Hoon, Michael A. Walter, John W.M. Martens, Andrea L. Richardson, Armando E. Giuliano, Xiaojiang Cui	2010	199
13	Identification of a Quantitative MINT Locus Methylation Profile Predicting Local Regional Recurrence of Rectal Cancer Clinical Cancer Research ·Michiel F.G. de Maat, Cornelis J.�H. van de Velde, Anne Benard, Hein Putter, Hans Morreau, J. Han van Krieken, Elma Meershoek‐Klein Kranenbarg, Eelco J. de Graaf, Rob A.�E.�M. Tollenaar, Dave S.�B. Hoon	2010	21
14	CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma Clinical Cancer Research ·Atsushi Tanemura, Alicia M. Terando, Myung‐Shin Sim, Anneke Q. van Hoesel, Michiel F.G. de Maat, Donald L. Morton, Dave S.�B. Hoon	2009	157
15	Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors Molecular Cancer Therapeutics ·Yasufumi Goto, Takaaki Arigami, Minoru Kitago, Sandy L. Nguyen, Norihiko Narita, Soldano Ferrone, Donald L. Morton, Reiko F. Irie, Dave S.�B. Hoon	2008	93
16	Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine Clinical Cancer Research ·Farin Amersi, Alicia M. Terando, Yasufumi Goto, Richard A. Scolyer, John F. Thompson, Andy N. Tran, Mark B. Faries, Donald L. Morton, Dave S.�B. Hoon	2008	114
17	The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis Clinical Cancer Research ·Simone Mocellin, Dave S.�B. Hoon, Alessandro Ambrosi, Donato Nitti, Carlo Riccardo Rossi	2006	170
18	A New Melanoma Antigen Fatty Acid–Binding Protein 7, Involved in Proliferation and Invasion, Is a Potential Target for Immunotherapy and Molecular Target Therapy Cancer Research ·Yasufumi Goto, Yuriko Matsuzaki, Sachiko Kurihara, Ayako Shimizu, Tsutomu Okada, Kazuhiko Yamamoto, Hiroshi Murata, Minoru Takata, Hiroyuki Aburatani, Dave S.�B. Hoon, Toshiaki Saida, Yutaka Kawakami	2006	48
19	The G691S RET Polymorphism Increases Glial Cell Line–Derived Neurotrophic Factor–Induced Pancreatic Cancer Cell Invasion by Amplifying Mitogen-Activated Protein Kinase Signaling Cancer Research ·Hirozumi Sawai, Yuji Okada, Kevork Kazanjian, Joseph Kim, Sascha Hasan, O. Joe Hines, Howard A. Reber, Dave S.�B. Hoon, Guido Eibl	2005	79
20	The Japanese Journal of Gastroenterological Surgery ·した障害の内訳は頸椎損傷例, 前分, と同時に患者にアまた不透過マーカーを用い大腸通過時間を測定した-検査, 査時の排便習慣を記録, した結果】症例, イクロアレイを用いた内視鏡下生検サンプルの遺析により, けるc-Metとvegf-, Dave S.�B. Hoon, 察をえた, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2004	1

About Dave S.�B. Hoon

Dave S.�B. Hoon is a scholar working on Cancer Research, Immunology, Oncology, Molecular Biology and Immunology and Allergy, having authored 407 papers that have together received 21.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (124 papers), Cancer Genomics and Diagnostics (90 papers), Epigenetics and DNA Methylation (57 papers), Cutaneous Melanoma Detection and Management (48 papers), Cancer Cells and Metastasis (44 papers), Cancer Immunotherapy and Biomarkers (42 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and CAR-T cell therapy research (24 papers). The work is most often cited by research in Cancer Research (7.8k citations), Oncology (9.7k citations), Immunology (5.9k citations), Molecular Biology (11.2k citations) and Pathology and Forensic Medicine (2.1k citations). Dave S.�B. Hoon has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Klaus Pantel, Heidi Schwarzenbach, Donald L. Morton, Christine Kuo, Roderick R. Turner, Armando E. Giuliano, Bret Taback, Hiroya Takeuchi, Anton J. Bilchik and Naoyuki Umetani. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, International Journal of Cancer and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact